Anti-Tumor Necrosis Factor Therapy for Pediatric IBD, Risk of Serious Infection and Lymphoma
Categories
Anti-Tumor Necrosis Factor Therapy for Pediatric IBD, Risk of Serious Infection and Lymphoma
Article: Clin Gastroenterol Hepatol. 2014 Sep;12(9):1443-51; quiz e88-9. doi: 10.1016/j.cgh.2014.01.021. Epub 2014 Jan 22.
Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.
Reviewer: Dr. Lance Robbins